MUÑOZ VENTURELLI, PAULA ANDREA
Preferred name
MUÑOZ VENTURELLI, PAULA ANDREA
Main Affiliation
Email
paumunoz@udd.cl
ORCID
0000-0003-1869-2255
Scopus Author ID
56071369200
118 results
Now showing 1 - 10 of 118
- Some of the metrics are blocked by yourconsent settings
Item type:Product, Dataset - Post-COVID-19 condition: a sex-based analysis of clinical and laboratory trends(2024); ; ; RIVIOTTA, AMY LISA3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection(BMJ, 2025-04); Sharon L Naismith<jats:sec> <jats:title>Introduction</jats:title> <jats:p>Increasing awareness of the high frequency, wide spectrum and disabling nature of symptoms that can persist following COVID-19 infection has prompted the investigation of management strategies. Our study aims to determine the effectiveness of atorvastatin on cognitive function, physical activity, mood, health-related quality of life and features of neurovascular impairment and neuroinflammation in adults with ongoing neurological symptoms after COVID-19 infection.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and analysis</jats:title> <jats:p>The STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy study is an ongoing international, investigator-initiated and conducted, multicentre, prospective, randomised, open label, blinded endpoint trial with fixed time points for outcome assessments. A total of 410 participants with long covid neurological symptoms were planned to be randomly assigned to either the intervention group to receive 40 mg atorvastatin for 12 months or to a control group of no treatment, on top of usual care.</jats:p> </jats:sec> <jats:sec> <jats:title>Ethics and dissemination</jats:title> <jats:p>This study protocol was designed, implemented and reported, in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice, the National Health and Medical Research Council of Australia, the National Statement on Ethical Conduct in Human Research and with the ethical principles laid down in the World Medical Association Declaration of Helsinki. Central ethics committee approval was obtained from Sydney Local Health District Royal Prince Alfred Hospital Ethics (No: X21-0113 and 2021/ETH00777 10) in Australia. Site-specific ethics committee approvals were obtained elsewhere before any local study activities. All participants provided written informed consent.</jats:p> </jats:sec> <jats:sec> <jats:title>Trial registration number</jats:title> <jats:p>The study protocol is registered at Clinicaltrials.gov (<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="clintrialgov" xlink:href="NCT04904536">NCT04904536</jats:ext-link>).</jats:p> </jats:sec>3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Search Results for WOS:001330264900057 (Accession Number) Recommendations for Implementing the INTERACT3 Care Bundle for Intracerebral Haemorrhage in Latin America: A delphi Study 1 of 1 Recommendations for Implementing the INTERACT3 Care Bundle for Intracerebral Haemorrhage in Latin America: A delphi Study(2024); 4 - Some of the metrics are blocked by yourconsent settings
Item type:Product, - Some of the metrics are blocked by yourconsent settings
Item type:Product, Dataset - Coupling between neural oscillations and white matter integrity reveals cognitive computational profiles following COVID-19(OpenEuro, 2026); ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Quality of Functional Outcome and its determinants in ICH. Insights from the INTERACT3 trial(2025); Anderson, Craig2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 8 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Addressing sex and gender differences in stroke risk and management: A scientific statement from the World Stroke Organization(SAGE Publications, 2025-10-23)1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Dysphagia screening and risks of pneumonia and adverse outcomes after acute stroke: An international multicenter study(2020)1Scopus© Citations 46